554 related articles for article (PubMed ID: 10926800)
21. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Cuzick J; Coibion M; Bianco AR
BJOG; 2003 Dec; 110(12):1099-106. PubMed ID: 14664881
[TBL] [Abstract][Full Text] [Related]
22. [Endometrial cancers arising in polyps associated with tamoxifen use].
Mbatsogo BA; Le Bouëdec G; Michy T; Bourdel N; Fouilloux G; Dauplat J
Gynecol Obstet Fertil; 2005 Dec; 33(12):975-9. PubMed ID: 16321556
[TBL] [Abstract][Full Text] [Related]
23. Tamoxifen and the endometrium: review of 102 cases and comparison with HRT-related and non-HRT-related endometrial pathology.
Kennedy MM; Baigrie CF; Manek S
Int J Gynecol Pathol; 1999 Apr; 18(2):130-7. PubMed ID: 10202670
[TBL] [Abstract][Full Text] [Related]
24. [Tamoxifen and endometrial pathology].
Negoiţă M; Terinte C; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
[TBL] [Abstract][Full Text] [Related]
25. Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients.
Cohen I; Bernheim J; Azaria R; Tepper R; Sharony R; Beyth Y
Gynecol Oncol; 1999 Oct; 75(1):136-41. PubMed ID: 10502440
[TBL] [Abstract][Full Text] [Related]
26. Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen.
Kesim MD; Aydin Y; Atis A; Mandiraci G
Climacteric; 2008 Jun; 11(3):252-7. PubMed ID: 18568790
[TBL] [Abstract][Full Text] [Related]
27. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
Swerdlow AJ; Jones ME;
J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
[TBL] [Abstract][Full Text] [Related]
28. [Postmenopausal hemorrhage and endometrial cancer in tamoxifen therapy].
Krause A; Gerber B
Zentralbl Gynakol; 1994; 116(1):44-7. PubMed ID: 8147180
[TBL] [Abstract][Full Text] [Related]
29. [Comparative study of the endometrial pathology using flexible ambulatory hysteroscopy of patients treated with Tamoxifen].
Kuzmanov B
Akush Ginekol (Sofiia); 2004; 43(3):32-3. PubMed ID: 15341254
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic study of 56 patients with endometrial cancer during or after adjuvant tamoxifen use for their breast cancers.
Hachisuga T; Saito T; Kigawa J; Ohwada M; Yamazawa K; Yasue A; Iwasaka T; Sugiyama T; Kita T; Nagai N
Gynecol Oncol; 2004 Oct; 95(1):139-44. PubMed ID: 15385123
[TBL] [Abstract][Full Text] [Related]
31. Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy.
Barakat RR; Gilewski TA; Almadrones L; Saigo PE; Venkatraman E; Hudis C; Hoskins WJ
J Clin Oncol; 2000 Oct; 18(20):3459-63. PubMed ID: 11032585
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of endometrial proliferation in pipelle biopsies in tamoxifen-treated postmenopausal women with breast cancer in Kuwait.
Al-Azemi M; Labib NS; Motawy MM; Temmim L; Moussa MA; Omu AE
Med Princ Pract; 2004; 13(1):30-4. PubMed ID: 14657616
[TBL] [Abstract][Full Text] [Related]
33. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.
Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K
J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586
[TBL] [Abstract][Full Text] [Related]
34. [Tamoxifen and giant endometrial polyps].
Caschetto S; Cassaro N; Consalvo P; Caragliano L
Minerva Ginecol; 2000 Nov; 52(11):459-63. PubMed ID: 11256174
[TBL] [Abstract][Full Text] [Related]
35. [Clinicopathological features of endometrial carcinoma in tamoxifen- and toremifene-treated breast cancer patients].
Otsuka I; Takahashi S; O'uchi K; Akimoto N; Hanari K; Ogaki Y; Enatsu YH; Takigawa A; Takaya H; Tanaka A; Kaseki H; Yamada T
Gan To Kagaku Ryoho; 2010 Feb; 37(2):279-83. PubMed ID: 20154485
[TBL] [Abstract][Full Text] [Related]
36. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
[TBL] [Abstract][Full Text] [Related]
37. Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy.
Corley D; Rowe J; Curtis MT; Hogan WM; Noumoff JS; Livolsi VA
Obstet Gynecol; 1992 Jan; 79(1):111-6. PubMed ID: 1727568
[TBL] [Abstract][Full Text] [Related]
38. Gynecologic tumors in tamoxifen-treated women with breast cancer.
Seoud MA; Johnson J; Weed JC
Obstet Gynecol; 1993 Aug; 82(2):165-9. PubMed ID: 8393156
[TBL] [Abstract][Full Text] [Related]
39. [Role of steroid hormones and related biological substances in the etiology of endometrial carcinomas].
Lang-Avérous G; Rupp K; Wehner H; Dallenbach-Hellweg G
Verh Dtsch Ges Pathol; 1991; 75():366-9. PubMed ID: 1724843
[TBL] [Abstract][Full Text] [Related]
40. Genomic changes in endometrial polyps associated with tamoxifen show no evidence for its action as an external carcinogen.
Dal Cin P; Timmerman D; Van den Berghe I; Wanschura S; Kazmierczak B; Vergote I; Deprest J; Neven P; Moerman P; Bullerdiek J; Van den Berghe H
Cancer Res; 1998 Jun; 58(11):2278-81. PubMed ID: 9622058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]